Photo from Yüksel Ürün/X
Dec 7, 2023, 19:07
Yüksel Ürün: New Study on Cancer Biomarkers!
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter:
“New Study on Cancer Biomarkers! Tumor Mutational Burden (TMB) shows mixed results as a predictor for immune therapy success. It works well for lung, head and neck, and urothelial cancers but not for melanoma or oesophagal/gastric cancers.
This study suggests we need more tailored approaches to predict therapy success, not a one-size-fits-all TMB measure.”
For details, click here.
Source: Yüksel Ürün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19